Rabourn Amy Zaremba serves as Executive at Ocuphire Pharma, Inc., where they oversee executive responsibilities. Since joining the company, Rabourn Amy Zaremba has executed 5 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jan 22, 2026 involved receiving (via award) 86,500 shares valued at $0.
Rabourn Amy Zaremba currently holds 193,128 shares of Ocuphire Pharma, Inc. (OCUP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Rabourn Amy Zaremba has been a net neutral trader of OCUP stock. They have purchased $0 and sold $0 worth of shares.
Rabourn Amy Zaremba's most recent insider trade was on Jan 22, 2026, when they sold 86,500 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $1.93 |
| Discretionary |
| Jan 18, 2024 | OCUP | $0 | Award | 40,000 | $N/A | Discretionary |
| Jan 10, 2024 | OCUP | $12.9K | Payment | 3,950 | $3.27 | Discretionary |
| Jan 10, 2023 | OCUP | $0 | Award | 46,608 | $N/A | Discretionary |